In this review, we comprehensively present the function of epigenetic regulations in normal
placental development as well as in a prominent disease of placental origin, preeclampsia …

Preeclampsia (PE), the leading cause of maternal and fetal morbidity and mortality, is
associated with poor fetal growth, intrauterine growth restriction (IUGR) and low birth weight …

Preeclampsia (PE) is a disorder affecting 2–10% of pregnancies and has a major role for
perinatal and maternal mortality and morbidity. PE can be occurred by initiation of new …

Strong evidence suggests a potential link among epigenetics, microRNAs (miRNAs), and
pregnancy complications. Much research still needs to be carried out to determine whether …

Background Preeclampsia (PE) is a heterogeneous, hypertensive disorder of pregnancy,
with no robust biomarkers or effective treatments. We hypothesized that this heterogeneity is …

Preeclampsia is a pregnancy disease affecting 5 to 8% of pregnant women and a leading
cause of both maternal and fetal mortality and morbidity. Because of a default in the process …

Preeclampsia is a potentially fatal pregnancy disorder affecting millions of women around
the globe. Dysregulation in gene and protein expression within key biological pathways …

Placental cortisol is inactivated in normotensive pregnancies, but is frequently present in pre-
eclampsia associated placentae. Since glucocorticoids are strongly associated with the …

Preeclampsia (PE), a hypertensive disorder of pregnancy, is hypothesized to be associated
with, if not mechanistically related to abnormal placental function. However, the exact …

Preeclampsia (PE) is a major cause of perinatal materno-foetal morbidity and pregnancy-
associated-mortality in industrialized countries. Clinically, PE associates maternal …